These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23665160)

  • 61. Spectral-Domain Optical Coherence Tomography Documentation of Transsynaptic Retinal Degeneration.
    Schwartz SG; Pasol J; Lam BL; Flynn HW
    Ophthalmic Surg Lasers Imaging Retina; 2016 Aug; 47(8):768-72. PubMed ID: 27548455
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses.
    Finn LS; Zhang M; Chen SH; Scott CR
    Am J Med Genet; 2000 Mar; 91(3):222-6. PubMed ID: 10756347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EDITORIAL: Special issue on the role of lipid and protein oxidation in retinal degenerations.
    Fliesler SJ; Ferrington DA
    Exp Eye Res; 2019 Apr; 181():313-315. PubMed ID: 30929716
    [No Abstract]   [Full Text] [Related]  

  • 64. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
    Sun Y; Liou B; Ran H; Skelton MR; Williams MT; Vorhees CV; Kitatani K; Hannun YA; Witte DP; Xu YH; Grabowski GA
    Hum Mol Genet; 2010 Mar; 19(6):1088-97. PubMed ID: 20047948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of Gaucher disease mutations found in Saudi Arabia.
    Kaya N; Al-Zahrani F; Al-Odaib A; Rahbeeni Z; Al-Hassnan Z; Al-Sharif F; Ozand P; Al-Sayed M
    Blood Cells Mol Dis; 2008; 41(2):200-1. PubMed ID: 18586535
    [No Abstract]   [Full Text] [Related]  

  • 66. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.
    Eblan MJ; Nguyen J; Ziegler SG; Lwin A; Hanson M; Gallardo M; Weiser R; De Lucca M; Singleton A; Sidransky E
    Mov Disord; 2006 Feb; 21(2):282-3. PubMed ID: 16261622
    [No Abstract]   [Full Text] [Related]  

  • 67. Simplified detection of Nci mutation in Gaucher disease.
    Dahl N; Lagerström M; Erikson A; Pettersson U
    Lancet; 1990 Jun; 335(8705):1589-90. PubMed ID: 1972504
    [No Abstract]   [Full Text] [Related]  

  • 68. Y418C: a novel mutation in exon 9 of the glucocerebrosidase gene of a patient with Gaucher disease creates a new Bgl I site.
    Tuteja R; Tuteja N; Lilliu F; Bembi B; Galanello R; Cao A; Baralle FE
    Hum Genet; 1994 Sep; 94(3):314-5. PubMed ID: 8076951
    [No Abstract]   [Full Text] [Related]  

  • 69. Gaucher disease: report of de novo GBA mutation in a Spanish family.
    Alfonso P; Pocovi M; Giraldo P
    Blood Cells Mol Dis; 2008; 40(3):444-5. PubMed ID: 18313951
    [No Abstract]   [Full Text] [Related]  

  • 70. Large soft-tissue masses in an adult patient with Gaucher disease.
    Mahajan N; Brynes R; Yano S
    J Inherit Metab Dis; 2016 Nov; 39(6):887-888. PubMed ID: 27503099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gaucher disease: four families with previously undescribed mutations.
    Beutler E; Gelbart T; Balicki D; Demina A; Adusumalli J; Elsas L; Grinzaid KA; Gitzelmann R; Superti-Furga A; Kattamis C; Liou BB
    Proc Assoc Am Physicians; 1996 May; 108(3):179-84. PubMed ID: 8774051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid screening of 10 common mutations in Turkish Gaucher patients using electronic DNA microarray.
    Ezgu F; Hasanoglu A; Okur I; Biberoglu G; Tumer L; Eminoglu T; Dogan H
    Blood Cells Mol Dis; 2008; 40(2):246-7. PubMed ID: 18035560
    [No Abstract]   [Full Text] [Related]  

  • 73. Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.
    Amaral O; Pinto E; Fortuna M; Lacerda L; Sá Miranda MC
    Hum Mutat; 1996; 8(3):280-1. PubMed ID: 8889591
    [No Abstract]   [Full Text] [Related]  

  • 74. Mutations causing Gaucher disease.
    Horowitz M; Zimran A
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Type 1 Gaucher disease in a pediatric patient: 12 year's evolution].
    García M; Casanova C; Chabás A; Viosca E; Martínez B
    Sangre (Barc); 1997 Jun; 42(3):227-9. PubMed ID: 9381267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fundal abnormalities of Gaucher's disease.
    Cogan DG; Chu FC; Gittinger J; Tychsen L
    Arch Ophthalmol; 1980 Dec; 98(12):2202-3. PubMed ID: 7447774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gaucher disease, a paradigm for single gene defects.
    Beutler E
    Experientia; 1995 Mar; 51(3):196-7. PubMed ID: 7698272
    [No Abstract]   [Full Text] [Related]  

  • 78. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse.
    Willemsen R; Tybulewicz V; Sidransky E; Eliason WK; Martin BM; LaMarca ME; Reuser AJ; Tremblay M; Westphal H; Mulligan RC
    Mol Chem Neuropathol; 1995; 24(2-3):179-92. PubMed ID: 7632321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interruption in enzyme replacement therapy for Gaucher disease.
    Weinreb NJ
    Br J Haematol; 2001 Jun; 113(4):1087-9. PubMed ID: 11442515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.